<h4>Background</h4>Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutant lung adenocarcinoma (LUAD) typically demonstrates limited response to neoadjuvant immunotherapy (NIT). The gene discussed is KRAS; the disease is lung adenocarcinoma.